MycoTechnology, the developer of a mushroom-based vegan protein, secured the capital in a round co-led by Bunge that included Kellogg and Continental Grain.

US-based food technology developer MycoTechnology has closed a $35m series B round co-led by Bunge Ventures, the corporate venture capital unit of agribusiness and food company Bunge. S2G and Emerson Collective co-led the round, which also featured agribusiness Continental Grain and Eighteen94 Capital, the investment arm of packaged food producer Kellogg Company. VC firm Seventure…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.